Tag: Vas Narasimhan

Novartis acquires kidney disease innovator Chinook Therapeutics

businessnewstoday- August 14, 2023

Swiss pharmaceutical giant Novartis has wrapped up the previously announced $3.5 billion acquisition of Seattle-based biopharmaceutical firm Chinook Therapeutics, Inc. This deal propels Novartis deeper ... Read More

Novartis to expand renal portfolio with Chinook Therapeutics acquisition

businessnewstoday- June 12, 2023

Novartis has announced its agreement to acquire Chinook Therapeutics, a clinical stage biopharmaceutical company based in Seattle, Washington in a deal worth up to around ... Read More

Novartis gets Leqvio FDA approval for reducing bad cholesterol levels

pallavi123- January 2, 2022

Novartis has secured approval from the US Food and Drug Administration (FDA) for its small interfering RNA (siRNA) therapy Leqvio (inclisiran) for its use in ... Read More

Novartis to buy US gene therapy company AveXis for $8.7bn

pallavi123- April 9, 2018

Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion deal to acquire US gene therapy company AveXis in a move ... Read More

GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn

pallavi123- March 28, 2018

Pharma acquisition news : GlaxoSmithKline (GSK) has agreed to buy out Swiss pharma company Novartis’ stake of 36.5% in their consumer healthcare joint venture (JV) ... Read More